Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Nov 25, 2016 $66.15 $66.90 $64.20 $66.45 59 519
Nov 23, 2016 $66.30 $68.25 $64.20 $65.70 189 774
Nov 22, 2016 $71.10 $73.65 $67.80 $67.95 169 686
Nov 21, 2016 $67.50 $71.10 $66.75 $70.20 123 468
Nov 18, 2016 $66.45 $68.10 $65.70 $66.45 114 028
Nov 17, 2016 $65.55 $68.85 $65.40 $66.45 143 799
Nov 16, 2016 $70.35 $71.85 $65.40 $65.70 185 874
Nov 15, 2016 $75.15 $75.30 $67.95 $71.55 245 226
Nov 14, 2016 $65.25 $74.10 $64.05 $73.80 384 901
Nov 11, 2016 $62.40 $65.10 $61.20 $64.80 211 371
Nov 10, 2016 $61.50 $63.00 $58.65 $62.55 253 687
Nov 09, 2016 $58.65 $62.10 $56.85 $60.45 353 011
Nov 08, 2016 $49.95 $59.55 $49.35 $56.70 478 568
Nov 07, 2016 $48.00 $50.40 $46.65 $49.35 122 293
Nov 04, 2016 $43.50 $46.95 $43.50 $46.35 176 033
Nov 03, 2016 $47.40 $47.55 $42.75 $43.05 213 533
Nov 02, 2016 $47.10 $48.15 $46.95 $47.25 163 087
Nov 01, 2016 $47.25 $47.85 $46.05 $46.80 114 487
Oct 31, 2016 $47.55 $48.15 $47.10 $47.25 92 553
Oct 28, 2016 $48.30 $49.50 $46.95 $47.70 147 260
Oct 27, 2016 $49.35 $49.95 $48.00 $48.45 104 253
Oct 26, 2016 $48.90 $49.95 $47.10 $48.45 126 447
Oct 25, 2016 $50.40 $50.40 $48.75 $48.90 120 413
Oct 24, 2016 $50.25 $51.00 $49.50 $50.40 70 713
Oct 21, 2016 $51.45 $51.45 $49.50 $50.10 79 960
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT